Glasgow Coma Scale (GCS) and FOUR score (also searched with alternate eponym spellings and descriptive terms, ICD-10: R40.2) represent the two principal clinical instruments utilized worldwide for standardizing the evaluation of impaired consciousness in acute brain injury, trauma, and critical care medicine1, 2. Originally established by Teasdale and Jennett in 1974, the Glasgow Coma Scale provides a rapid tripartite assessment of eye-opening, verbal performance, and motor responsiveness2. Despite its widespread adoption and profound prognostic value, the traditional GCS faces inherent limitations in intubated, aphasic, or severely paralyzed patients who cannot generate a verbal response. To address these clinical deficiencies, the Full Outline of UnResponsiveness (FOUR) score was developed and validated as a comprehensive alternative that incorporates evaluation of eye movements, motor function, brainstem reflexes (pupillary and corneal reflexes), and respiratory patterns2, 3. Together, these scoring systems enable clinicians to quantify neurological deterioration, guide triage decisions in emergency departments, and accurately prognosticate outcomes in neurocritical care environments3, 4.

Etiology & Risk Factors

  • Traumatic Brain Injury (TBI): Encompassing blunt or penetrating head trauma resulting from motor vehicle collisions, falls, assaults, and sports-related concussions or contusions5.
  • Acute Cerebrovascular Events: Massive ischemic strokes, intracerebral hemorrhages, ruptured saccular aneurysms leading to subarachnoid hemorrhage, and basilar artery thrombosis causing brainstem ischemia3.
  • Hypoxic-Ischemic Encephalopathy: Global cerebral hypoperfusion secondary to cardiac arrest, severe systemic hypotension, near-drowning, or asphyxiation.
  • Toxic-Metabolic Derangements: Severe hepatic encephalopathy, uremic encephalopathy, acute diabetic ketoacidosis, non-ketotic hyperosmolar state, severe hyponatremia, and exogenous intoxications (e.g., opioids, sedatives, alcohols)4.
  • Central Nervous System Infections: Acute bacterial meningitis, herpes simplex virus encephalitis, brain abscesses, and cerebral malaria resulting in raised intracranial pressure.
  • Structural and Neoplastic Lesions: Primary or metastatic brain tumors associated with extensive vasogenic edema and secondary mass effect or midline shift.
  • Status Epilepticus: Prolonged convulsive or non-convulsive seizure activity leading to post-ictal depression or ongoing metabolic exhaustion.

Pathophysiology

Impaired consciousness arises from direct structural damage or metabolic suppression of the ascending reticular activating system (ARAS)—located within the brainstem tegmentum—or widespread bilateral cerebral hemispheric dysfunction1, 2. When a primary insult occurs, such as a subdural hematoma or an expanding intracerebral hemorrhage, local mass effect triggers localized ischemia, cytotoxic and vasogenic edema, and elevated intracranial pressure (ICP)5. As ICP increases, cerebral perfusion pressure (calculated as mean arterial pressure minus intracranial pressure) drops, causing global ischemia. Unchecked intracranial hypertension drives tissue downward, resulting in uncal herniation (compressing the third cranial nerve and causing ipsilateral papillary dilation) or central transtentorial herniation2, 5. These mechanical shifts disrupt brainstem centers controlling respiratory drive, vasomotor tone, and basic autonomic reflexes, which are captured progressively by decrements in both the GCS and FOUR score parameters.

Glasgow Coma Scale (GCS) and FOUR score — Pathophysiological Cascade & Clinical Flowchart 1 Primary Neurological Insult Acute structural or metabolic disruption of the ascending reticular activating system (ARAS) or bihemispheric cortex 2 Pathophysiological Cascade Cytotoxic or vasogenic edema, intracranial hypertension, and progressive brainstem compression 3 Target Organ / Structural Change Loss of cranial nerve reflexes, respiratory rhythm deregulation, and uncal or central herniation 4 Hallmark Clinical Manifestation Depressed level of consciousness, loss of verbal or motor command execution, and absent brainstem reflexes 5 Therapeutic Target & Intervention Reversal of secondary brain injury through intracranial pressure management and cerebral perfusion optimization

Clinical Presentation & Classic Clinical Signs

  • History & Cardinal Symptoms: Patients present with acute or progressive decline in alertness, ranging from mild lethargy and confusion to deep, unarousable coma. Family members or paramedics frequently report witnessed trauma, sudden collapse, focal neurological deficits, or preceding systemic symptoms such as fever or headache.
  • Physical Examination & Named Clinical Signs: Examination reveals altered mental status, absent or abnormal verbal output, and impaired motor responses2. Key examination findings include decorticate posturing (flexion of upper extremities and extension of lower extremities, indicating hemispheric white matter or internal capsule lesions) and decerebrate posturing (extension, adduction, and hyperpronation of upper extremities, reflecting more caudal brainstem dysfunction at the level of the upper pons). Pupillary asymmetry, loss of light reflexes, and irregular respiratory patterns (such as Cheyne-Stokes respiration or ataxic breathing) signal impending herniation2.

Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

Diagnostic Modality / Test Expected Clinical & Radiological / Laboratory Finding
Gold-Standard InvestigationNon-contrast head computed tomography (CT) scan demonstrating acute hemorrhage, skull fracture, midline shift, effacement of basal cisterns, or herniation syndromes.
Laboratory PanelComplete blood count, comprehensive metabolic panel, arterial blood gases, serum toxicology screen, blood cultures, ammonia levels, and coagulation profile to identify metabolic or infectious etiologies.
Imaging / Radiology (X-ray, US, CT, MRI)Brain magnetic resonance imaging (MRI) with diffusion-weighted imaging (DWI) and fluid-attenuated inversion recovery (FLAIR) sequences for subtle ischemic strokes, diffuse axonal injury, or encephalitis; chest radiography to rule out aspiration pneumonia.
ECG / Histopathology / Procedural12-lead electrocardiogram to evaluate for primary cardiac arrhythmias or ST-elevation myocardial infarction precipitating syncope or arrest; continuous electroencephalography (cEEG) to rule out non-convulsive status epilepticus.

Staging, Classification & Clinical Scoring Systems

Criterion / Stage / Score Component Clinical Threshold, Points & Management Implication
Glasgow Coma Scale (GCS) - Total ScoreRange: 3 to 15. Severe brain injury (3–8), moderate brain injury (9–12), minor brain injury (13–15). GCS ≤ 8 mandates definitive airway protection via endotracheal intubation.
GCS - Eye Opening (E)4 = Spontaneous; 3 = To verbal command; 2 = To pain; 1 = No response. Evaluates primary arousal pathways.
GCS - Verbal Response (V)5 = Oriented; 4 = Confused conversation; 3 = Inappropriate words; 2 = Incomprehensible sounds; 1 = No response. Evaluates higher cortical integration.
GCS - Motor Response (M)6 = Obeys commands; 5 = Localizes to pain; 4 = Withdraws from pain; 3 = Abnormal flexion (decorticate); 2 = Abnormal extension (decerebrate); 1 = No response. Strongest predictor of neurological outcome.
FOUR Score - Total ScoreRange: 0 to 16, comprising four domains scored 0 to 4 each: Eye, Motor, Brainstem, and Respiration. Evaluates brainstem integrity directly without relying on a verbal component.
FOUR Score - Brainstem (B)4 = Pupillary and corneal reflexes present; 3 = One pupil wide and fixed; 2 = Pupillary or corneal reflex absent; 1 = Pupillary and corneal reflexes absent; 0 = Absent reflexes, absent cough, or myoclonus status.
FOUR Score - Respiration (R)4 = Not intubated, regular breathing pattern; 3 = Not intubated, Cheyne-Stokes breathing; 2 = Not intubated, irregular breathing; 1 = Ventilated, breathes above ventilator rate; 0 = Ventilated, apnea or ataxic breathing.

Differential Diagnosis

Differential Condition Distinguishing Clinical, Biochemical & Imaging Features
Locked-In SyndromeCaused by ventral pontine infarction (e.g., basilar artery thrombosis). Patients are fully conscious and aware but quadriplegic and unable to speak; vertical eye movements and blinking are preserved, yielding a falsely low GCS/FOUR motor score unless specifically tested.
Psychogenic Unresponsiveness (Conversion Disorder)Normal pupillary light reflexes, active resistance to eye opening, intact corneal reflexes, and normal caloric testing with absent organic structural lesions on neuroimaging.
Persistent Vegetative State (Unresponsive Wakefulness Syndrome)Presence of sleep-wake cycles and preserved autonomic functions with complete absence of behavioral awareness of self or environment.
Acute Drug Intoxication / OverdoseHistory of exposure or elevated serum toxicology screening; typically exhibits symmetrical pupils (pinpoint in opioids, dilated in anticholinergics or sympathomimetics) and progressive improvement with supportive care or antagonists (e.g., naloxone).

Management & Treatment Protocol

  • Initial Stabilization & Resuscitation: Institute the ABCDE approach (Airway, Breathing, Circulation, Disability, Exposure). Secure the airway immediately via rapid sequence intubation if the GCS is 8 or lower, the FOUR score indicates severe brainstem depression, or airway protective reflexes are lost. Maintain target arterial oxygen saturation > 94% and normocapnia (PaCO2 35–45 mmHg) to prevent secondary ischemic injury.
  • First-Line Medical / Pharmacological Therapy (with exact adult dosing): Optimize cerebral perfusion pressure (CPP > 60–70 mmHg) utilizing isotonic crystalloids (normal saline or lactated Ringer's) and vasoactive infusions (e.g., norepinephrine infusion titrated from 0.05 to 0.5 mcg/kg/min) if hypotension occurs. For elevated intracranial pressure, administer Mannitol 20% (0.5 to 1.0 g/kg intravenous bolus over 20 minutes) or Hypertonic Saline 3% (100 to 250 mL intravenous bolus over 15 to 20 minutes) under ICP monitoring guidance. Administer prophylactic anti-seizure therapy with Levetiracetam (1000 to 1500 mg IV loading dose, followed by 500 to 1000 mg IV every 12 hours) in patients with traumatic brain injury or acute hemorrhage.
  • Surgical / Interventional Indications: Urgent neurosurgical decompression via craniotomy, decompressive craniectomy, or evacuation of space-occupying extra-axial hematomas (epidural or subdural) or insertion of an external ventricular drain (EVD) for acute obstructive hydrocephalus.

Complications & Prognosis

  • Acute Complications: Aspiration pneumonia, neurogenic pulmonary edema, deep vein thrombosis and pulmonary embolism due to prolonged immobilization, stress-induced gastrointestinal ulceration, and intracranial herniation syndromes resulting in irreversible brain death3, 5.
  • Chronic Complications: Post-traumatic epilepsy, spasticity, contractures, heterotopic ossification, cognitive deficits, and long-term dependence on institutionalized or caregiver support.
  • Prognosis: Morbidity and mortality correlate directly with the depth and duration of coma upon presentation, age of the patient, etiology of the insult (anoxic-ischemic encephalopathy carrying a significantly worse prognosis than metabolic encephalopathy), and serial trajectory of the GCS or FOUR score over the first 48 to 72 hours3, 4.